0001540171-12-000003.txt : 20121116 0001540171-12-000003.hdr.sgml : 20121116 20121116133220 ACCESSION NUMBER: 0001540171-12-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20121116 DATE AS OF CHANGE: 20121116 EFFECTIVENESS DATE: 20121116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genoa Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001540171 IRS NUMBER: 452463191 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-187115 FILM NUMBER: 121211016 BUSINESS ADDRESS: STREET 1: 12636 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (619) 992-6488 MAIL ADDRESS: STREET 1: 12636 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 D 1 primary_doc.xml X0706 D LIVE 0001540171 Genoa Pharmaceuticals, Inc. 12636 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA CALIFORNIA 92130 (619) 992-6488 DELAWARE None None Corporation true 2011 Mark W. Surber, Ph.D. 12636 High Bluff Dr. Suite 400 San Diego CA CALIFORNIA 92130 Executive Officer Director Richard G. Vincent 12636 High Bluff Dr. Suite 400 San Diego CA CALIFORNIA 92130 Executive Officer Michael J. Kamdar 12636 High Bluff Dr. Suite 400 San Diego CA CALIFORNIA 92130 Executive Officer Director Daniel D. Burgess 12636 High Bluff Dr. Suite 400 San Diego CA CALIFORNIA 92130 Director Pharmaceuticals Decline to Disclose 06 false 2011-10-23 true true true true false 1 1200000 1090000 110000 false 22 0 0 0 false Genoa Pharmaceuticals, Inc. /s/ Mark W. Surber, Ph.D. Mark W. Surber President and CEO 2012-11-16